TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Entera Bio to Participate in the 8th Annual Evercore ISI Healthcare Conference

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Miranda Toledano
Entera Bio to Participate in the 8th Annual Evercore ISI Healthcare Conference

Entera Bio's CEO will participate in the Evercore ISI Healthcare Conference, highlighting the company's progress in developing oral peptide therapies for conditions like osteoporosis and hypoparathyroidism.

Insights
VNQ   positive

Provides broad REIT sector exposure, low expense ratio (0.13%), over 3.5% dividend yield, and produced 7.5% average annual return since inception


ENTX   positive

The company is presenting positive clinical trial data for EB613, demonstrating consistent bone density improvements across different postmenopausal women age groups, and has received FDA agreement on bone mineral density as a primary endpoint for their Phase 3 study